chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, SARS-CoV-2 test positive, Wheezing
Clinical narrative: I tested positive for COVID 12/26/2021. My primary symptoms is that I felt very time, headache, lost of taste and smell, I notice that I started feeling shortness of breath and wheezing. I couldn't clean the house or take a walk without having to stop a few times because my breath was short. It lasted for about a month. That's when I decide to go see my PCP. He did a exam and he said that since I had COVID my symptoms was from that. He prescribe me an inhaler and I am still using that. He said that if it hadn't improve then we will explore some other options.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID Breakthrough. Patient tested positive for COVID on 2/25/22 while admitted to the hospital for other reasons. Patient is asymptomatic for COVID.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Colitis ulcerative, Condition aggravated
Clinical narrative: Second dose (February 21) and booster (December 21) both caused flare ups of my ulcerative colitis that had been in remission for about six years. Ended up having to be admitted to the hospital to manage the flare up.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, COVID-19, Chest X-ray normal, Chronic obstructive pulmonary disease, Chronic respiratory failure
Clinical narrative: a 61 y.o. male with COPD on home oxygen, who presented with shortness of breath.  He started to have increasing dyspnea 3 days ago.  Has had cough, non-productive.  Had fever at home.  No sick contacts.  Denies chest pain.  Found to be COVID-19 positive.  Wears 2-3 L O2 at home."   Hospital Course:  The patient was admitted to the hospital and was evaluated and treated per below.      * COPD with acute exacerbation Acute COPD Exacerbation - with associated COVID-19 viral infection.  Continue nebs, inhalers, IV steroids and antibiotics. Patient improved gradually and was feeling back to his baseline.   COVID-19 infection - CXR no infiltrates and is on his home O2 requirement of 2-3L with no increased need for oxygen supplementation.  Not fully vaccinated, had one dose Moderna 2/6/22.  Discussed with patient and given comborbid conditions will order remdesivir for at least 3 day course.  Continued at baseline oxygen requirement. Patient was feeling back to his baseline and was offered 2 more days of treatment. He declined and felt that he is ready to go home. Was discharged accordingly on a tapering course of prednisone. Follow up outpatient with primary care provider.    Chronic hypoxic respiratory failure - on home O2 2.5L.  Monitor closely.    Paroxysmal A fib - rate controlled.  Order betapace.  Not on OAC at home.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Cough, Dyspnoea, Multimorbidity, Pyrexia
Clinical narrative: a 61 y.o. male with COPD on home oxygen, who presented with shortness of breath.  He started to have increasing dyspnea 3 days ago.  Has had cough, non-productive.  Had fever at home.  No sick contacts.  Denies chest pain.  Found to be COVID-19 positive.  Wears 2-3 L O2 at home."   Hospital Course:  The patient was admitted to the hospital and was evaluated and treated per below.      * COPD with acute exacerbation Acute COPD Exacerbation - with associated COVID-19 viral infection.  Continue nebs, inhalers, IV steroids and antibiotics. Patient improved gradually and was feeling back to his baseline.   COVID-19 infection - CXR no infiltrates and is on his home O2 requirement of 2-3L with no increased need for oxygen supplementation.  Not fully vaccinated, had one dose Moderna 2/6/22.  Discussed with patient and given comborbid conditions will order remdesivir for at least 3 day course.  Continued at baseline oxygen requirement. Patient was feeling back to his baseline and was offered 2 more days of treatment. He declined and felt that he is ready to go home. Was discharged accordingly on a tapering course of prednisone. Follow up outpatient with primary care provider.    Chronic hypoxic respiratory failure - on home O2 2.5L.  Monitor closely.    Paroxysmal A fib - rate controlled.  Order betapace.  Not on OAC at home.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: a 61 y.o. male with COPD on home oxygen, who presented with shortness of breath.  He started to have increasing dyspnea 3 days ago.  Has had cough, non-productive.  Had fever at home.  No sick contacts.  Denies chest pain.  Found to be COVID-19 positive.  Wears 2-3 L O2 at home."   Hospital Course:  The patient was admitted to the hospital and was evaluated and treated per below.      * COPD with acute exacerbation Acute COPD Exacerbation - with associated COVID-19 viral infection.  Continue nebs, inhalers, IV steroids and antibiotics. Patient improved gradually and was feeling back to his baseline.   COVID-19 infection - CXR no infiltrates and is on his home O2 requirement of 2-3L with no increased need for oxygen supplementation.  Not fully vaccinated, had one dose Moderna 2/6/22.  Discussed with patient and given comborbid conditions will order remdesivir for at least 3 day course.  Continued at baseline oxygen requirement. Patient was feeling back to his baseline and was offered 2 more days of treatment. He declined and felt that he is ready to go home. Was discharged accordingly on a tapering course of prednisone. Follow up outpatient with primary care provider.    Chronic hypoxic respiratory failure - on home O2 2.5L.  Monitor closely.    Paroxysmal A fib - rate controlled.  Order betapace.  Not on OAC at home.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: I started with a sore throat & runny nose so i spoke with doctor on telehealth call & went to urgent care & tested positive for Covid-19.
Age: 9.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Multisystem inflammatory syndrome in children
Clinical narrative: Multisystem inflammatory syndrome in children, associated with COIVD-19
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Brain death, Brain scan abnormal, Computerised tomogram head abnormal, Craniectomy, Death
Clinical narrative: Ruptured Cerebral Aneurysm Left Middle Cerebral Artery Circulation (02/25/2022) leading to death (02/27/2022)
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Haematoma evacuation, Intra-cerebral aneurysm operation, Mechanical ventilation, Ruptured cerebral aneurysm
Clinical narrative: Ruptured Cerebral Aneurysm Left Middle Cerebral Artery Circulation (02/25/2022) leading to death (02/27/2022)
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray, Echocardiogram, Electrocardiogram, Heart rate increased, Laboratory test
Clinical narrative: I woke up with vertigo and increased heartrate. My heartrate continued to be elevated, especially at night, for about a month following the vaccine. I still experience a little vertigo from time to time--my doctor has diagnosed me with orthostatic hypotension.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Orthostatic hypotension, Vertigo
Clinical narrative: I woke up with vertigo and increased heartrate. My heartrate continued to be elevated, especially at night, for about a month following the vaccine. I still experience a little vertigo from time to time--my doctor has diagnosed me with orthostatic hypotension.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood test, Joint range of motion decreased, Pain, Paraesthesia
Clinical narrative: Development of chronic hip pain in left hip which has not subsided in 10 months.  No previous injuries, wounds or pain in this area.  Dr. suspects development of Rheumatoid Arthritis.  Also swelling of legs and development of varicose veins over the past year where there were none before.  Treatment for hip - bloodwork, rheumatologist involved, physical therapy, exercises, tylenol.  Outcome of hip - ongoing, chronic, unresolved pain and decreased range of motion.  Leg treatment - bloodwork, compression socks.  Outcome of legs - ongoing swelling, tingling, unresolved
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Rheumatoid arthritis, Varicose vein
Clinical narrative: Development of chronic hip pain in left hip which has not subsided in 10 months.  No previous injuries, wounds or pain in this area.  Dr. suspects development of Rheumatoid Arthritis.  Also swelling of legs and development of varicose veins over the past year where there were none before.  Treatment for hip - bloodwork, rheumatologist involved, physical therapy, exercises, tylenol.  Outcome of hip - ongoing, chronic, unresolved pain and decreased range of motion.  Leg treatment - bloodwork, compression socks.  Outcome of legs - ongoing swelling, tingling, unresolved
Age: 52.0
Sex: M
Vaccine: UNK
Symptoms: Superficial vein thrombosis, Ultrasound Doppler abnormal
Clinical narrative: I formed a superficial thrombosis blood clot in my left foot.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: patient was given pfizer vacccine by health department on 2/24/22 and then we gave janssen to the patient on 2/25/22. On our consent form we ask the patient "Have you recieved another vaccine in the past 14 days" which the patient answered "No" to.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy
Clinical narrative: Painful and extremely swollen lymph nodes in neck by left collar bone and in left armpit. Larger than a quarter since 02/23/2022. Still large and painful on 02/28/2022 (today).
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Menstrual disorder, Oligomenorrhoea
Clinical narrative: After booster shot (2 days later) it induced a menstrual cycle outside of my schedule (I'm on birth control) with severe cramping for one week which subsided. Menstrual cycle has lasted 14 days and has not stopped.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood lactic acid abnormal, COVID-19, Computerised tomogram thorax normal, Cough, Dyspnoea
Clinical narrative: Reports worsening shortness of breath associated fever, cough however no chest pain, palpitations, nausea or vomiting.  Denies any changes in urinary or bowel habits  -  ED workup significant for tachycardia, tachypnea, positive COVID-19 swab, abnormal lactic acid initial 2.2, 1.3 on repeat after sepsis fluids. (02/23/2022 21:26 EST CT Chest PE W Contrast) 1. Limited examination but no evidence of a large central pulmonary artery embolus.  2. Findings at both lung bases that may just represent some atelectatic changes however infection cannot be entirely excluded Admitted 2/23/22 - 2/25/22.  Previously vaccinated Pfizer 3/18/21; 4/8/21
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Scan with contrast normal, Tachycardia, Tachypnoea
Clinical narrative: Reports worsening shortness of breath associated fever, cough however no chest pain, palpitations, nausea or vomiting.  Denies any changes in urinary or bowel habits  -  ED workup significant for tachycardia, tachypnea, positive COVID-19 swab, abnormal lactic acid initial 2.2, 1.3 on repeat after sepsis fluids. (02/23/2022 21:26 EST CT Chest PE W Contrast) 1. Limited examination but no evidence of a large central pulmonary artery embolus.  2. Findings at both lung bases that may just represent some atelectatic changes however infection cannot be entirely excluded Admitted 2/23/22 - 2/25/22.  Previously vaccinated Pfizer 3/18/21; 4/8/21
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Blood test, Pruritus, Steroid therapy
Clinical narrative: Approximately 48 hours after my 1st dose I experienced the following symptoms: I lost hair from my scalp and several different locations. My head was really itchy and I had a lot of hair falling out of my head. I went to the doctor and she diagnosed me having Alopecia and they applied steroids in my scalp as treatment - it was an ongoing condition for me until I had my 2nd dose vaccination (Moderna) the hair fall has gotten so much worse. It took me 3-4 rounds of steroids treatment until I have recovered. Up to this day I still experience  the same symptom but in a different part of my head and still continue to receive the steroid treatment.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Decreased appetite, Diarrhoea, Injection site pain, Lethargy
Clinical narrative: Lethargy, malaise, headache/migraine, nausea, diarrhea, fever, pain at injection site, decreased appetite, muscle aches, memory fog, cough. Lasted about 8 days. Spoke with MD, f/u appointment in March.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Memory impairment, Migraine, Myalgia, Nausea
Clinical narrative: Lethargy, malaise, headache/migraine, nausea, diarrhea, fever, pain at injection site, decreased appetite, muscle aches, memory fog, cough. Lasted about 8 days. Spoke with MD, f/u appointment in March.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Lethargy, malaise, headache/migraine, nausea, diarrhea, fever, pain at injection site, decreased appetite, muscle aches, memory fog, cough. Lasted about 8 days. Spoke with MD, f/u appointment in March.
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Multisystem inflammatory syndrome in children
Clinical narrative: Multisystem Inflammatory Syndrome in Children, associated with COVID 19
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Diarrhoea haemorrhagic, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Patient presented with cough, SOB, and diarrhea with blood and was COVID positive
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Sluggishness
Clinical narrative: fatigue, sluggish, headache, rundown
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash, no wheezing
Age: 60.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Otitis media, Physical examination, Rhinitis allergic, SARS-CoV-2 test negative
Clinical narrative: Otitis media, Allergic Rhinitis.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Blood lactic acid, COVID-19, Confusional state, Death, Fibrin D dimer increased
Clinical narrative: a 74 y.o. male resident who was sent here for above problems. He contracted Covid-19 infection after he was sent there on 2/12 for rehab. He tested (+) on 2/21. He was severely hypotensive on arrival here and confused. He has been started on pressor agent. UA show signs of infection. D dimer 1139, lactate 9.5, procalcitonin 1.8. He is confused.  Later same day, his conditioned worsened and the outcome was clear, patient was made DNR and was provided comfort care until his passing,
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: General physical health deterioration, Hypotension, Infection, Procalcitonin, SARS-CoV-2 test positive
Clinical narrative: a 74 y.o. male resident who was sent here for above problems. He contracted Covid-19 infection after he was sent there on 2/12 for rehab. He tested (+) on 2/21. He was severely hypotensive on arrival here and confused. He has been started on pressor agent. UA show signs of infection. D dimer 1139, lactate 9.5, procalcitonin 1.8. He is confused.  Later same day, his conditioned worsened and the outcome was clear, patient was made DNR and was provided comfort care until his passing,
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Urine analysis abnormal
Clinical narrative: a 74 y.o. male resident who was sent here for above problems. He contracted Covid-19 infection after he was sent there on 2/12 for rehab. He tested (+) on 2/21. He was severely hypotensive on arrival here and confused. He has been started on pressor agent. UA show signs of infection. D dimer 1139, lactate 9.5, procalcitonin 1.8. He is confused.  Later same day, his conditioned worsened and the outcome was clear, patient was made DNR and was provided comfort care until his passing,
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, SARS-CoV-2 test positive
Clinical narrative: incidental finding, asymptomatic with positive PCR for covid-19 on 2/18/22. Patient remained asymptomatic
Age: 1.33
Sex: M
Vaccine: FLU4, HEPA, MMR, PNC13
Symptoms: Pyrexia, Rash, Restlessness
Clinical narrative: Rash on legs that spread to face, back and arms. Started on 2/26/2022, low grade fever with temperature reaching a max of 100.9 and restless at night on 2/26/22 and 2/27/22
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Dermatitis, Rash
Clinical narrative: Two weeks after the second vaccine really bad rash on my face broke out and eye brows loss hair, saw dermatologist diagnosed it as dermatitis provided topical cream.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: The vaccine was given past the beyond use date. Moderna was notified and per Moderna that vaccine maintained the necessary activity to protect against COVID-19. No additional intervention required.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy test, Blood test normal, Mechanical urticaria, Urticaria
Clinical narrative: urticaria 11 days after booster; persistent dermatographia since booster (for 2 months now)
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaphylactic reaction, Angioedema, Anti-thyroid antibody, Blood immunoglobulin E normal, C-reactive protein normal
Clinical narrative: Extreme itching and dermatographic hives, angioedema of hands/feet/scalp. Anaphylactic reaction in throat/chest, prescribed prednisone on 12/4 due to this. After prednisone, angioedema and anaphylaxis gone but hives still present 24/7. On multiple doses of OTC antihistamines around the clock ever since. Keeps hives/itching at bay for the most part but still having dermatographic swelling of skin. If I miss a dose, the hives reappear. Many blood tests including allergy tests came back negative, no discernable cause for this.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Full blood count normal, Mechanical urticaria, Metabolic function test, Pruritus, Red blood cell sedimentation rate normal
Clinical narrative: Extreme itching and dermatographic hives, angioedema of hands/feet/scalp. Anaphylactic reaction in throat/chest, prescribed prednisone on 12/4 due to this. After prednisone, angioedema and anaphylaxis gone but hives still present 24/7. On multiple doses of OTC antihistamines around the clock ever since. Keeps hives/itching at bay for the most part but still having dermatographic swelling of skin. If I miss a dose, the hives reappear. Many blood tests including allergy tests came back negative, no discernable cause for this.
Age: 25.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Skin swelling
Clinical narrative: Extreme itching and dermatographic hives, angioedema of hands/feet/scalp. Anaphylactic reaction in throat/chest, prescribed prednisone on 12/4 due to this. After prednisone, angioedema and anaphylaxis gone but hives still present 24/7. On multiple doses of OTC antihistamines around the clock ever since. Keeps hives/itching at bay for the most part but still having dermatographic swelling of skin. If I miss a dose, the hives reappear. Many blood tests including allergy tests came back negative, no discernable cause for this.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site rash
Clinical narrative: Red itchy bumps running along from injection site.  Morning of 2/27/22 appeared to current. Informed PCM, took 1 Benadryl 2/27/22 in the evening.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Computerised tomogram normal, Hypoaesthesia oral, Magnetic resonance imaging abnormal
Clinical narrative: On Nov 16th, my mouth started feeling numb so my son took me to the doctor. They gave me a CT scan but told me I didn't have a stroke.  I went back the next day and was still told I didn't have a stroke.  They sent me home w/ prednisone.  A few days later, I checked myself into hospital and stayed over night and had another MRI which revealed I had a small stroke.  They put me on aspirin and Lipitor.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Pt was given pediatric Pfizer vaccine on 13th birthday.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest pain, Dyspnoea, Fatigue, Influenza A virus test
Clinical narrative: nausea/vomiting for 3 days prior to 2/18/22; chest pain, sob, syncope, fatigued with body aches.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza B virus test, Nausea, Nucleic acid test, Pain, SARS-CoV-2 test positive
Clinical narrative: nausea/vomiting for 3 days prior to 2/18/22; chest pain, sob, syncope, fatigued with body aches.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Syncope, Vomiting
Clinical narrative: nausea/vomiting for 3 days prior to 2/18/22; chest pain, sob, syncope, fatigued with body aches.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: patient received Pfizer vaccine intended for 5-11 year olds instead of the 12+
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products, No adverse event
Clinical narrative: Client presented to ECC vaccination site to receive Janssen Booster.  Client informed RN that when she received Pfizer series dose 1 on 12/30/20 and Pfizer dose 2 1/18/21, Client states she developed hives all over the body and fever the same night of both doses 5-6 hrs. after the vaccine. Client denies having shortness of breath, and no itching. Client took Tylenol for symptoms. Client states she didn?t seek emergency care. Client?s primary care provider Dr informed her it was a normal reaction and was ok for her to receive Pfizer booster. Client has no known allergies and no medical conditions. It?s never happened with other vaccines. She?s here to get Janssen, although Dr didn?t recommend Janssen, but recommended Pfizer. Client is afraid of getting Pfizer again. RN submitted a medical consult. MD approved for client to receive Janssen booster. Client was vaccinated with Janssen booster lot#1855191 by RN. Client was educated on Emergency precautions and signs and symptoms of blood clots. Client waited in observation area for 30 minutes, no symptoms were reported. Client left vaccination site in a steady gait.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arteriovenous fistula thrombosis, Aspiration pleural cavity, COVID-19, Pleural effusion, Pneumonia
Clinical narrative: 70 y.o. F w PMH of ESRD on HD, Bipolar disorder, Cognitive impairment/Dementia with activated POA/court appointed lives in (Privacy) SNF, hx of VTE, SDH s/p resection, paroxysmal a-fib who presents with the hospital as a transfer for a clotted fistula. She was admitted on 2/11 at the hospital for a very large left pleural effusion and CAP. She had 2 L drained via thoracentesis which was exudative in nature. Did not require a chest tube. She was initially started on IV vancomycin, cefepime and was transitioned to IV rocephin and azithromycin.   She also tested positive for COVID 19 and was given IV dexamethasone.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: 70 y.o. F w PMH of ESRD on HD, Bipolar disorder, Cognitive impairment/Dementia with activated POA/court appointed lives in (Privacy) SNF, hx of VTE, SDH s/p resection, paroxysmal a-fib who presents with the hospital as a transfer for a clotted fistula. She was admitted on 2/11 at the hospital for a very large left pleural effusion and CAP. She had 2 L drained via thoracentesis which was exudative in nature. Did not require a chest tube. She was initially started on IV vancomycin, cefepime and was transitioned to IV rocephin and azithromycin.   She also tested positive for COVID 19 and was given IV dexamethasone.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Blood glucose increased, COVID-19 pneumonia, Computerised tomogram thorax abnormal, Glycosylated haemoglobin increased
Clinical narrative: 52-year-old male  Initially admitted to the hospital on 02/10/22 with COVID-19 pneumonia.    During the course of admission patient underwent CT chest PE which identified no pulmonary embolism on 02/10/22; CT chest was repeated on 02/19/2020 to to evaluate for pulmonary embolism and identified no acute pulmonary embolism.  Both CT scans identified diffuse pulmonary nodule consolidative ground-glass opacities throughout the bilateral lungs.  Additionally patient underwent ultrasound lower extremities which identified no DVTs bilaterally.  During the course of admission patient was found to have pneumomediastinum; deemed to be likely secondary to positive-pressure positive-pressure ventilation setting of BiPAP and high-flow; discussed with vascular surgery adjusted inspiratory pressure; patient was hemodynamically stable throughout the whole admission; no signs of acute pneumothorax or tamponade, no signs of compression of the IVC.  Serial chest x-ray remains stable.  During the course of admission patient continued to downtrend on O2 requirement; on the day of discharge patient was saturating well on 3 L of O2 via nasal cannula and underwent walk study which he failed.  Was sent home with O2.  During the course of admission patient was found to have elevated blood sugars; hemoglobin A1c: 10; discussed the possible need for insulin with patient which he did not want.  Therefore was discharged home with occasions including glipizide and metformin.  Discussed with him the Augmentin Augmentin results in the setting of chronic steroid use during prolonged admission.  During the course for admission patient reported that he had severe anxiety which was contributing to his hypoxia; therefore was discharged home with a 3 day course of anxiolytics; discussed red flag symptoms with these medications.  Additionally patient was found to be hypertensive therefore patient was started on antihypertensives.  Discussed to follow-up in outpatient setting with PCP.    Admitted 2/10/22 - 2/25/22 Moderna 7/29/21 & 8/26/21
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypertension, Hypoxia, Lung opacity, Pneumomediastinum, Positive airway pressure therapy
Clinical narrative: 52-year-old male  Initially admitted to the hospital on 02/10/22 with COVID-19 pneumonia.    During the course of admission patient underwent CT chest PE which identified no pulmonary embolism on 02/10/22; CT chest was repeated on 02/19/2020 to to evaluate for pulmonary embolism and identified no acute pulmonary embolism.  Both CT scans identified diffuse pulmonary nodule consolidative ground-glass opacities throughout the bilateral lungs.  Additionally patient underwent ultrasound lower extremities which identified no DVTs bilaterally.  During the course of admission patient was found to have pneumomediastinum; deemed to be likely secondary to positive-pressure positive-pressure ventilation setting of BiPAP and high-flow; discussed with vascular surgery adjusted inspiratory pressure; patient was hemodynamically stable throughout the whole admission; no signs of acute pneumothorax or tamponade, no signs of compression of the IVC.  Serial chest x-ray remains stable.  During the course of admission patient continued to downtrend on O2 requirement; on the day of discharge patient was saturating well on 3 L of O2 via nasal cannula and underwent walk study which he failed.  Was sent home with O2.  During the course of admission patient was found to have elevated blood sugars; hemoglobin A1c: 10; discussed the possible need for insulin with patient which he did not want.  Therefore was discharged home with occasions including glipizide and metformin.  Discussed with him the Augmentin Augmentin results in the setting of chronic steroid use during prolonged admission.  During the course for admission patient reported that he had severe anxiety which was contributing to his hypoxia; therefore was discharged home with a 3 day course of anxiolytics; discussed red flag symptoms with these medications.  Additionally patient was found to be hypertensive therefore patient was started on antihypertensives.  Discussed to follow-up in outpatient setting with PCP.    Admitted 2/10/22 - 2/25/22 Moderna 7/29/21 & 8/26/21
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pulmonary mass, SARS-CoV-2 test positive, Ultrasound Doppler normal, Walking distance test abnormal
Clinical narrative: 52-year-old male  Initially admitted to the hospital on 02/10/22 with COVID-19 pneumonia.    During the course of admission patient underwent CT chest PE which identified no pulmonary embolism on 02/10/22; CT chest was repeated on 02/19/2020 to to evaluate for pulmonary embolism and identified no acute pulmonary embolism.  Both CT scans identified diffuse pulmonary nodule consolidative ground-glass opacities throughout the bilateral lungs.  Additionally patient underwent ultrasound lower extremities which identified no DVTs bilaterally.  During the course of admission patient was found to have pneumomediastinum; deemed to be likely secondary to positive-pressure positive-pressure ventilation setting of BiPAP and high-flow; discussed with vascular surgery adjusted inspiratory pressure; patient was hemodynamically stable throughout the whole admission; no signs of acute pneumothorax or tamponade, no signs of compression of the IVC.  Serial chest x-ray remains stable.  During the course of admission patient continued to downtrend on O2 requirement; on the day of discharge patient was saturating well on 3 L of O2 via nasal cannula and underwent walk study which he failed.  Was sent home with O2.  During the course of admission patient was found to have elevated blood sugars; hemoglobin A1c: 10; discussed the possible need for insulin with patient which he did not want.  Therefore was discharged home with occasions including glipizide and metformin.  Discussed with him the Augmentin Augmentin results in the setting of chronic steroid use during prolonged admission.  During the course for admission patient reported that he had severe anxiety which was contributing to his hypoxia; therefore was discharged home with a 3 day course of anxiolytics; discussed red flag symptoms with these medications.  Additionally patient was found to be hypertensive therefore patient was started on antihypertensives.  Discussed to follow-up in outpatient setting with PCP.    Admitted 2/10/22 - 2/25/22 Moderna 7/29/21 & 8/26/21
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Death
Clinical narrative: PT HAD VACCINES.  EVENTUALLY DEVELOPED COVID, AND PASSED.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Axillary pain, Chest pain, Dyspnoea, Echocardiogram, Electrocardiogram
Clinical narrative: Severe chest pain, shortness of breath, nausea, fever, fainting (did not go unconscious), arm and armpit pain
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nausea, Pain in extremity, Pyrexia, Syncope
Clinical narrative: Severe chest pain, shortness of breath, nausea, fever, fainting (did not go unconscious), arm and armpit pain
Age: 94.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, Infection, SARS-CoV-2 test positive
Clinical narrative: COVID Breakthrough. Patient tested positive for COVID on 2/24/22and is asymptomatic.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray, Dyspnoea, Pulmonary congestion, SARS-CoV-2 test
Clinical narrative: My lungs begin to get congested over a couple months. I had to used inhaler and other medicine. I was not able to breathe and not able to take a deep breath.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Alanine aminotransferase increased, Anxiety, Arrhythmia, Aspartate aminotransferase increased, Basedow's disease
Clinical narrative: Arrhythmia, elevated blood pressure, tremors, anxiety, and poor digestion.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood test, Blood thyroid stimulating hormone decreased, Dyspepsia, Hyperthyroidism
Clinical narrative: Arrhythmia, elevated blood pressure, tremors, anxiety, and poor digestion.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Thyroxine free increased, Tremor
Clinical narrative: Arrhythmia, elevated blood pressure, tremors, anxiety, and poor digestion.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: tested positive for covid , incidental finding, tested for placement in nursing home
Age: 19.0
Sex: F
Vaccine: HEPA
Symptoms: Underdose
Clinical narrative: Patient received 1/2 dose of vaccination (19 years old). Patient to receive full dose of vaccine since 6 months has passed since invalid dose was given.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: Numbess around lips and cheeks. BP:140/80 Pulse: 88/min Benadryl 50mg given.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Chills, Dyspnoea, Fatigue, Productive cough
Clinical narrative: COVID infection tested positive on 02/12/2022 fully vaccinated, recent hospitalization 1/31 -2/3 for HFrEF (37.5% EF) exacerbation, neurogenic bowel and bladder with colostomy d/t back injury from MVA at 14yo, left buttock pressure wound, PVD s/p left BKA, h/o recurrent spontaneous L PTX s/p VATS with mechanical and talc pleurodesis and history of tobacco abuse (36 pack year) who is presenting from home with dyspnea.  Symptoms began on 2/11 and included productive cough, chest congestion, shortness of breath, fatigue and fevers/chills. She had been doing well since her last admission and initially daughter was concerned that she had heart failure again but went to get tested for covid and that resulted positive on 2/12.
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: COVID infection tested positive on 02/12/2022 fully vaccinated, recent hospitalization 1/31 -2/3 for HFrEF (37.5% EF) exacerbation, neurogenic bowel and bladder with colostomy d/t back injury from MVA at 14yo, left buttock pressure wound, PVD s/p left BKA, h/o recurrent spontaneous L PTX s/p VATS with mechanical and talc pleurodesis and history of tobacco abuse (36 pack year) who is presenting from home with dyspnea.  Symptoms began on 2/11 and included productive cough, chest congestion, shortness of breath, fatigue and fevers/chills. She had been doing well since her last admission and initially daughter was concerned that she had heart failure again but went to get tested for covid and that resulted positive on 2/12.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue
Clinical narrative: Client disclosed she developed dizziness 3 hours after receiving the first dose of COVID vaccine Janssen. The client stated the dizziness lasted 6-7 hours. The client also reported feeling tired after receiving the first dose of Janssen COVID vaccine.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Acoustic stimulation tests abnormal, Deafness, Hearing aid user, Tinnitus
Clinical narrative: Ringing in ear, continued to get worse after second vaccine, pressure, and loss of hearing.  After booster, head is completely roaring and ringing and hearing loss has worsened.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray normal, Chest pain, Cough
Clinical narrative: Presents to the hospital with cough chest pain which is exacerbated with deep inspiration. ED workup significant for hypoxia 84% on 4 L, mild hypokalemia and chest x-ray without acute findings; on admission patient was found of (+) sirs with tachypnea tachycardia; found to (+)-COVID-19 pneumonia.  Patient was admitted to the hospital; started on medications including dexamethasone, Combivent, azithromycin and received remdesivir.  During the course of admission is S upper and lower extremity DVT is ruled out.  Patient continued to improve improve and requiring less O2 supplementation as compared to on admission.  Prior to discharge patient will using 2 L of O2 (baseline).   Admitted 2/23/22-2/27/22 Pfizer 5/23/21 & 6/15/21
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypokalaemia, Hypoxia, Inappropriate schedule of product administration, Painful respiration, SARS-CoV-2 test positive
Clinical narrative: Presents to the hospital with cough chest pain which is exacerbated with deep inspiration. ED workup significant for hypoxia 84% on 4 L, mild hypokalemia and chest x-ray without acute findings; on admission patient was found of (+) sirs with tachypnea tachycardia; found to (+)-COVID-19 pneumonia.  Patient was admitted to the hospital; started on medications including dexamethasone, Combivent, azithromycin and received remdesivir.  During the course of admission is S upper and lower extremity DVT is ruled out.  Patient continued to improve improve and requiring less O2 supplementation as compared to on admission.  Prior to discharge patient will using 2 L of O2 (baseline).   Admitted 2/23/22-2/27/22 Pfizer 5/23/21 & 6/15/21
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Systemic inflammatory response syndrome, Tachycardia, Tachypnoea, Ultrasound Doppler normal
Clinical narrative: Presents to the hospital with cough chest pain which is exacerbated with deep inspiration. ED workup significant for hypoxia 84% on 4 L, mild hypokalemia and chest x-ray without acute findings; on admission patient was found of (+) sirs with tachypnea tachycardia; found to (+)-COVID-19 pneumonia.  Patient was admitted to the hospital; started on medications including dexamethasone, Combivent, azithromycin and received remdesivir.  During the course of admission is S upper and lower extremity DVT is ruled out.  Patient continued to improve improve and requiring less O2 supplementation as compared to on admission.  Prior to discharge patient will using 2 L of O2 (baseline).   Admitted 2/23/22-2/27/22 Pfizer 5/23/21 & 6/15/21
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Rash
Clinical narrative: Rash all over my skin from scalp to toe. Body feels on fire. Intensifies in evening. On-going from 4 months. Have to take anti allergy medicine every day.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, C-reactive protein increased, Musculoskeletal pain, Musculoskeletal stiffness, Pain
Clinical narrative: 4/27/2021: "64-year-old gentleman presents with pain that started about 3 to 4 days after he received the J&J vaccine.  It affected both on arms and shoulders with soreness in the right was always worse than the left.  It hurts to raise his arms and this gradually progressed.  He normally exercises and works out with weights and is usually good doing that without problems.  He has an occasional left shoulder tweak that improves with rest in the past.  However, the symptoms are different and has actually worsened.  He had tried OTC Aleve which helps.  Tylenol does not work.  He has more symptoms and more pain when he does not take Aleve or Advil.  He also noted pain to affect both hips and buttocks in addition to his"...arms and shoulders.  There is mild morning stiffness usually lasting about 5 minutes and affects his hands.  Moving his fingers and hands would help.  He was given IM Toradol 60 mg with Solu-Medrol 125 mg and he felt significant improvement immediately.  He is currently taking prednisone 40 mg daily for 3 days now and is supposed to take that for 7 days."
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Red blood cell sedimentation rate increased
Clinical narrative: 4/27/2021: "64-year-old gentleman presents with pain that started about 3 to 4 days after he received the J&J vaccine.  It affected both on arms and shoulders with soreness in the right was always worse than the left.  It hurts to raise his arms and this gradually progressed.  He normally exercises and works out with weights and is usually good doing that without problems.  He has an occasional left shoulder tweak that improves with rest in the past.  However, the symptoms are different and has actually worsened.  He had tried OTC Aleve which helps.  Tylenol does not work.  He has more symptoms and more pain when he does not take Aleve or Advil.  He also noted pain to affect both hips and buttocks in addition to his"...arms and shoulders.  There is mild morning stiffness usually lasting about 5 minutes and affects his hands.  Moving his fingers and hands would help.  He was given IM Toradol 60 mg with Solu-Medrol 125 mg and he felt significant improvement immediately.  He is currently taking prednisone 40 mg daily for 3 days now and is supposed to take that for 7 days."
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Ischaemic stroke
Clinical narrative: Ischemic STROKE
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine given on the Left Deltoid. Vaccine was given 3 hours after beyond used time.
Age: 77.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Dysphagia, SARS-CoV-2 test positive
Clinical narrative: Presents to the hospital with dysphagia and borderline blood pressures.  Referred per primary care physician.  During the course of admission patient was found to have (+) COVID-19.  Patient did not have any hypoxia, did not require supplementation throughout the admission.  Did not require inpatient management for COVID-19. Admitted 2/23/22-2/26/22 Pfizer 3/1/21, 3/23/21 & 12/24/21
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: The Moderna vaccine with lot # 003C21A that was sent out on 11/24/21 to our clinic should have the absolute expiration date of 12/17/21 and not 12/24/2021.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: gave 0.5 ml instead of 0.25 ml
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray, Chest discomfort, Chest pain, Dyspnoea, Headache
Clinical narrative: About 2 weeks of the vaccine, I started getting tightness in my chest for 2 days and I got more symptoms, day 3 I had tightness in chest and pain in my chest day 4 same thing. day 5 same but shortness of breathing. I had to use my inhaler it didn't work so I had to go to the emergency they gave me a breathing treatment it worked but not a lot.  I got my doctor's appointment, and she gave me medication not sure it worked but I still have it. Day after ER I still have the same symptoms. I had a headache for 2 days along with other symptoms. short of breath, pain with breathing my inhaler didn't work so I took hot shower it helped a little. Still now I have same symptoms. its' getting better but very slowly.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test, Painful respiration
Clinical narrative: About 2 weeks of the vaccine, I started getting tightness in my chest for 2 days and I got more symptoms, day 3 I had tightness in chest and pain in my chest day 4 same thing. day 5 same but shortness of breathing. I had to use my inhaler it didn't work so I had to go to the emergency they gave me a breathing treatment it worked but not a lot.  I got my doctor's appointment, and she gave me medication not sure it worked but I still have it. Day after ER I still have the same symptoms. I had a headache for 2 days along with other symptoms. short of breath, pain with breathing my inhaler didn't work so I took hot shower it helped a little. Still now I have same symptoms. its' getting better but very slowly.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Fatigue, SARS-CoV-2 test
Clinical narrative: 2/19/22 fatigue, weakness, diarrhea
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Hordeolum, Nasal discomfort
Clinical narrative: Sores inside nose as well as styes in both eyes.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood culture negative, Brain herniation, COVID-19, Craniocerebral injury, Dysphagia
Clinical narrative: 75 y.o. Caucasian female with history of HTN, HLD, a fib not on anticoagulation, and recurrent falls at home culminating in a traumatic SDH complicated by uncal herniation and TBI in October 2021 with slow recovery in the interim, and recent candidemia who presents with shortness of breath in setting of known COVID infection.  Patient was hospitalized in January 2022 for sepsis secondary to aspiration pneumonia.  Hospitalization was also complicated by candidemia and dysphagia.  She was treated with standard antibiotics for pneumonia and a 2 week course of micafungin for candidemia.  Repeat blood cultures were negative.  Although she had previously been receiving nutrition via NG tube, after working with speech path ology she was was advanced to a soft diet with nectar thickened liquids.  She discharged to a nursing facility for ongoing care on 01/26/2022.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Fall, Pneumonia, Pneumonia aspiration, Sepsis
Clinical narrative: 75 y.o. Caucasian female with history of HTN, HLD, a fib not on anticoagulation, and recurrent falls at home culminating in a traumatic SDH complicated by uncal herniation and TBI in October 2021 with slow recovery in the interim, and recent candidemia who presents with shortness of breath in setting of known COVID infection.  Patient was hospitalized in January 2022 for sepsis secondary to aspiration pneumonia.  Hospitalization was also complicated by candidemia and dysphagia.  She was treated with standard antibiotics for pneumonia and a 2 week course of micafungin for candidemia.  Repeat blood cultures were negative.  Although she had previously been receiving nutrition via NG tube, after working with speech path ology she was was advanced to a soft diet with nectar thickened liquids.  She discharged to a nursing facility for ongoing care on 01/26/2022.
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Subdural haematoma, Systemic candida
Clinical narrative: 75 y.o. Caucasian female with history of HTN, HLD, a fib not on anticoagulation, and recurrent falls at home culminating in a traumatic SDH complicated by uncal herniation and TBI in October 2021 with slow recovery in the interim, and recent candidemia who presents with shortness of breath in setting of known COVID infection.  Patient was hospitalized in January 2022 for sepsis secondary to aspiration pneumonia.  Hospitalization was also complicated by candidemia and dysphagia.  She was treated with standard antibiotics for pneumonia and a 2 week course of micafungin for candidemia.  Repeat blood cultures were negative.  Although she had previously been receiving nutrition via NG tube, after working with speech path ology she was was advanced to a soft diet with nectar thickened liquids.  She discharged to a nursing facility for ongoing care on 01/26/2022.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19 pneumonia, Convalescent plasma transfusion, Mechanical ventilation, Respiratory failure
Clinical narrative: was recently treated with baricitinib and dexamethasone for COVID-19 pneumonia in early February elsewhere. Progressive respiratory failure due to critical COVID-19 pneumonia, requiring mechanical ventilation/proning - initially treated elsewhere with dexamethasone and baricitinib (without antivirals or antibodies), now started on remdesivir and convalescent plasma  Vaccine given at (Privacy)
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Endotracheal intubation, Mechanical ventilation, Respiratory failure
Clinical narrative: was recently treated with baricitinib and dexamethasone for COVID-19 pneumonia in early February elsewhere. Progressive respiratory failure due to critical COVID-19 pneumonia, requiring mechanical ventilation/proning - initially treated elsewhere with dexamethasone and baricitinib (without antivirals or antibodies), now started on remdesivir and convalescent plasma  Vaccine given at (Privacy)
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: The Moderna vaccine with lot # 003C21A that was sent out on 11/24/21 to our clinic should have the absolute expiration date of 12/17/21 and not 12/24/2021.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Throat tightness
Clinical narrative: RASH ON UPPER PART OF HER BODY  AND THROAT CLOSING